Skip to main content
. 2020 Mar 30;10(1):010405. doi: 10.7189/jogh.10.010405

Table 7.

Summary of human genetic factors associated with nasopharyngeal carcinoma

Potential risk factor References
Angiogenesis:
VEGF
[S32,S33]
Apoptosis

FAS/FAS-L
[S34-S36]
Red blood cell antigens
[61] [S37-S40]
Cell cycle, growth and differentiation:
CCND1
[S41,S42]
EGF, EGFR
[S43]
MDM2
[S44-S46]
TP53
[S45,S47-S51]
Cellular adhesion:
CD44
[S52]
CDH1
[S53]
MMP
[S54,S55]
Cellular chaperones:
HSP-70
[S56]
Cytokines and chemokines:
IFN-A
[S48]
IFN-G
[S57,S58]
IFN-GR1
[S59]
IL-1A/B
[S59-S61]
IL-1RN
[S59,S62]
IL-2
[S63]
IL-4RA
[S59]
IL-8
[S58,S64,S65]
IL-10
[S57,S59,S66-68]
IL-12
[S69,S70]
IL-16
[S71]
IL-18
[S66,S72,S73]
IL-27
[S70]
TGFB
[S74,S75]
TNFA
[S56,S76,S77]
DNA damage and repair:
General
[S78,S79]
BPIFA1
[S80]
ERCC1
[S81]
ERCC2
[S82]
hOGG1
[S83]
NBS1
[S84]
XPC
[S85]
XRCC1
[S82,S83,S86,S87]
XRCC3
[S82,S88]
HLA and associated genes:
HCGA9
[S59]
HLA region/type
[S38,S40,S89-S115]
HLA-A
[S59,S116-S118]
HLA-DQ
[S119,S120]
HLA-DR
[S120]
HLA-E
[S121-S123]
HLA-G
[S124]
MICA
[S125,S126]
TAP1
[S127,S128]
Inflammation:
COX-2
[S129]
MAPKAPK2
[S130]
Metabolism:
CYP1A1
[S1,S131]
CYP2A6
[S1]
CYP2E1
[89] [S1,S132-S137]
GSTM1
[S1,S131,S138-S147]
GSTP1
[S131,S133,S144]
GSTT1
[S1,S131,S138,S140-S142,S144,S147]
MPO
[S133]
MTHFR
[S148]
NAT2
[S131,S138]
NQO1
[S133]
MicroRNAs:
MIR34
[S149]
Multiple
[S150]
Other immune-related:

CR2
[S151-S153]
CTLA4
[S154]
DC SIGN
[S155]
IGK
[S156]
KIR
[S90,S96,S157]
PIGR
[S152,S158,S159]
TLR3
[S160]
TLR4
[S161]
TLR10
[S162]
Other:
ACE
[S163]
BPIFA1 (PLUNC)
[S164]
CAV-1
[S165]
DLC-1
[S166]
IKB
[S167]
MAP2K4
[S168]
N4BP2
[S169]
NFKB
[S167,S170]
VDR
[S171]
Genome wide-association study/other screening approaches [57,68,72] [S142,S172-S182]

*References marked with letter S are available in the Online Supplementary Document.